PubMed=21293464; DOI=10.1038/nbt.1783
Boulting G.L., Kiskinis E., Croft G.F., Amoroso M.W., Oakley D.H., Wainger B.J., Williams D.J., Kahler D.J., Yamaki M., Davidow L.S., Rodolfa C.T., Dimos J.T., Mikkilineni S., MacDermott A.B., Woolf C.J., Henderson C.E., Wichterle H., Eggan K.C.
A functionally characterized test set of human induced pluripotent stem cells.
Nat. Biotechnol. 29:279-286(2011)

PubMed=21295703; DOI=10.1016/j.cell.2010.12.032
Bock C., Kiskinis E., Verstappen G., Gu H.-C., Boulting G.L., Smith Z.D., Ziller M.J., Croft G.F., Amoroso M.W., Oakley D.H., Gnirke A., Eggan K.C., Meissner A.
Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.
Cell 144:439-452(2011)

PubMed=24704492; DOI=10.1016/j.stem.2014.03.004
Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., Wainger B.J., Han S., Peng T., Thams S., Mikkilineni S., Mellin C., Merkle F.T., Davis-Dusenbery B.N., Ziller M.J., Oakley D.H., Ichida J.K., Di Costanzo S., Atwater N., Maeder M.L., Goodwin M.J., Nemesh J., Handsaker R.E., Paull D.J., Noggle S.A., McCarroll S.A., Joung J.K., Woolf C.J., Brown R.H., Eggan K.C.
Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.
Cell Stem Cell 14:781-795(2014)